cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2006; 48:2161-2167, doi:10.1016/j.jacc.2006.08.031 (Published online 8 November 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipsic, E.
Right arrow Articles by van Gilst, W. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lipsic, E.
Right arrow Articles by van Gilst, W. H.

Protective Effects of Erythropoietin in Cardiac Ischemia

From Bench to Bedside

Erik Lipsic, MD, PhD*,{dagger},*, Regien G. Schoemaker, PhD*, Peter van der Meer, MD, PhD*,{dagger}, Adriaan A. Voors, MD, PhD{dagger}, Dirk J. van Veldhuisen, MD, PhD, FACC{dagger} and Wiek H. van Gilst, PhD*,{dagger}

*Clinical Pharmacology
{dagger} Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands


Figure 1
View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Biological functions of erythropoietin (EPO). Classical hematopoietic effect and 2 mechanisms by which EPO renders cardioprotection in experiments.

 




 
  cardiology careers collections past issues search home